SPY316.18+2.40 0.76%
DIA260.72+1.68 0.65%
IXIC10,492.50+148.61 1.44%

Titan Pharmaceuticals And Indegene Enter Into Probuphine Co-Promotion Partnership

SAN FRANCISCO, June 24, 2020 /PRNewswire/ --Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) ("Titan" or the "Company") today announced that it has entered into a co-promotion partnership with

Benzinga · -

SAN FRANCISCO, June 24, 2020 /PRNewswire/ --Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) ("Titan" or the "Company") today announced that it has entered into a co-promotion partnership with Indegene Inc. to establish multichannel digital marketing programs throughout the United States and expand the capabilities for the engagement of health care providers ("HCPs") who are eligible to prescribe Titan's Probuphine®(buprenorphine)implant.